Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 12
Submit an article Journal homepage
95
Views
3
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Natalizumab in multiple sclerosis: proceed with caution?

POLMAN CH, O’CONNOR PW, HAVRDOVA E et al.: A randomised, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. (2006) 354:899-910, RUDICK RA, STUART WH, CALABRESI PA et al.: Natalizumab plus interferon-b1a for relapsing multiple sclerosis. N. Engl. J. Med. (2006) 354:911-923, and YOUSRY TA, MAJOR EO, RYSCHKEWITSCH C et al.: Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N. Engl. J. Med. (2006) 354:924-933.

Sheila A Doggrell Senior Lecturer, School of Science, Charles Darwin University, PO Box 41246, Casuarina, Northern Territory, 0811 Australia. [email protected]
Pages 1675-1678 | Published online: 28 Jul 2006

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sheila A Doggrell. (2007) Is fingolimod an advancement in the treatment of multiple sclerosis?. Expert Opinion on Pharmacotherapy 8:3, pages 383-386.
Read now

Articles from other publishers (2)

Adrian CORDOȘ M., Simina BARAC I. & F. Dafin MUREȘANU. (2020) The twisted role of natalizumab and rehabilitation in an aggressive form of multiple sclerosis: a case report. Balneo Research Journal:Vol.11, no.4, pages 580-584.
Crossref
Si-Yuan Pan, Si-Bao Chen, Hong-Guang Dong, Zhi-Ling Yu, Ji-Cui Dong, Zhi-Xian Long, Wang-Fun Fong, Yi-Fan Han & Kam-Ming Ko. (2011) New Perspectives on Chinese Herbal Medicine (Zhong-Yao) Research and Development. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.